You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sirolimus

Showing 51 - 75 of 335
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplant Infection Trial in São Paulo (Sirolimus, Everolimus, Mycophenolic acid)

Completed
  • Kidney Transplant Infection
  • Sirolimus
  • +2 more
  • São Paulo, Sao Paulo, Brazil
    Hospital do Rim
Aug 23, 2021

Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland

Not yet recruiting
  • Secondary Malignant Neoplasm of Retroperitoneum
  • +2 more
  • Intestinal, Multivisceral or Modified Multivisceral Transplantation
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023

Cancer Trial in United States (Sirolimus, Celecoxib, Etoposide)

Recruiting
  • Cancer
  • Sirolimus
  • +3 more
  • Phoenix, Arizona
  • +5 more
Oct 28, 2021

Arteriovenous Malformations Trial in Belgium, France (Sirolimus)

Recruiting
  • Arteriovenous Malformations
  • Sirolimus
  • Bruxelles, Belgium
  • +12 more
Aug 23, 2021

Age-Related Macular Degeneration, Geographic Atrophy Trial run by the NEI (Sirolimus)

Completed
Has Results
  • Age-Related Macular Degeneration
  • Geographic Atrophy
  • Sirolimus
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 14, 2021

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
Has Results
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Lupus Nephritis, Immunosuppression, Effect of Drug Trial (Sirolimus)

Not yet recruiting
  • Lupus Nephritis
  • +2 more
  • Sirolimus
  • (no location specified)
May 13, 2021

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Seattle

Terminated
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 3, 2021

Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

Recruiting
  • Congenital Hemolytic Anemia
  • Sickle Cell Disease
  • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Complication of Renal Dialysis, End Stage Renal Disease, End Stage Kidney Disease Trial in United States (drug, procedure,

Completed
  • Complication of Renal Dialysis
  • +7 more
  • Sirolimus
  • +2 more
  • Huntsville, Alabama
  • +3 more
Jul 21, 2021

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

Recruiting
  • Sickle Cell Anemia
  • Beta Thalassemia
  • TBI
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Sarcoma, Malignant Peripheral Nerve Sheath Tumors Trial in United States (PLX3397, Sirolimus)

Recruiting
  • Sarcoma
  • Malignant Peripheral Nerve Sheath Tumors
  • Iowa City, Iowa
  • +4 more
Aug 26, 2021

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Acute Rejection of Liver Transplant, Effects of Immunosuppressant Therapy Trial in Chicago (Sirolimus)

Completed
  • Acute Rejection of Liver Transplant
  • Effects of Immunosuppressant Therapy
  • Sirolimus
  • Chicago, Illinois
    Northwestern University
Mar 4, 2021

Primary Renal Allograft Trial in Cincinnati (mycophenolate mofetil, sirolimus)

Completed
  • Primary Renal Allograft
  • mycophenolate mofetil
  • sirolimus
  • Cincinnati, Ohio
  • +1 more
Jul 8, 2021

Safety and Durability of Sirolimus for Treatment of LAM

Recruiting
  • Lymphangioleiomyomatosis
  • Stanford, California
  • +19 more
Jan 11, 2022

HIV-1 Infection Trial in United States (Sirolimus)

Completed
Has Results
  • HIV-1 Infection
  • Sirolimus
  • San Francisco, California
  • +9 more
Jul 30, 2021

Lupus Erythematosus, Systemic Trial (Sirolimus, Placebo)

Not yet recruiting
  • Lupus Erythematosus, Systemic
  • Sirolimus
  • Placebo
  • (no location specified)
Feb 1, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Idiopathic Pulmonary Fibrosis, Diffuse Parenchymal Lung Disease, Interstitial Lung Disease Trial in Gainesville (sirolimus,

Completed
  • Idiopathic Pulmonary Fibrosis
  • +2 more
  • sirolimus
  • Placebo
  • Gainesville, Florida
    University of Florida
Mar 19, 2021

Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome, Tufted Angioma Trial in United States (Vincristine, Sirolimus)

Terminated
Has Results
  • Kaposiform Hemangioendothelioma (KHE)
  • +2 more
  • Palo Alto, California
  • +6 more
May 20, 2021

GVHD (GvHD) Trial in Cardiff (Thymoglobulin, Cyclophosphamide, Cyclosporine)

Recruiting
  • Graft Versus Host Disease (GvHD)
  • Cardiff, Wales, United Kingdom
    University Hospital of Wales
May 10, 2021